CaloSense Health

Better Chronic Obesity Management: Driven By Data, Powered By AI & Delivered By Humans

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in April 2020 by Nitzan Shenar and Alon Ezra, CaloSense Health operates with 1–10 employees. The company has secured $2.56 million in total capital across nine funding rounds from seven investors. In January 2026, CaloSense Health raised a Seed round with.

Business overview

CaloSense Health provides a fully managed care platform for chronic obesity management, leveraging data, AI, and human-led care. The company's core product is a Remote Patient Monitoring (RPM) system that tracks patient data via connected devices, enabling real-time, personalized interventions. Initially focused on the bariatric surgery space, CaloSense Health helps clinics improve outcomes and scale operations by offering structured pre- and post-surgery support. The platform is designed for seamless integration into clinic workflows, is fully reimbursed by insurers, and operates across the U.S., aiming to increase adherence and reduce dropout rates for patients with severe obesity. CaloSense Health operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring, utilizing Artificial Intelligence and Machine Learning technologies to serve healthcare providers.

Strategic signal

In January 2026, CaloSense Health completed a Seed funding round, with. This capital injection underscores ongoing investor confidence in CaloSense Health's AI-powered chronic obesity management platform and its potential for market expansion and technological advancement within the digital healthcare landscape.

Log in to access full profile

Company Intelligence Q&A

When was CaloSense Health founded and by whom?
CaloSense Health was founded in April 2020 by Co-founders Nitzan Shenar and Alon Ezra.
What is CaloSense Health's primary focus in healthcare?
CaloSense Health primarily focuses on chronic obesity management, particularly in the bariatric surgery space, by providing a fully managed care platform driven by data, AI, and human support.
What significant funding event occurred in January 2026?
In January 2026, CaloSense Health raised a Seed funding round, with.
What type of grant did CaloSense Health receive in February 2024?
In February 2024, CaloSense Health secured a grant from the Israel Innovation Authority.
Which investors participated in CaloSense Health's April 2022 funding round?
In April 2022, CaloSense Health received funding from Comda and Techstars Tel Aviv Accelerator.
Log in to access full profile